Abstract
Objectives
During normal menstrual cycles, serum levels of progesterone vary widely between cycles of same woman and between women. This study investigated the profiles of pregnanediol during the luteal phase.
Methods
Data stemmed from a previous multicenter prospective observational study and concerned 107 women (who contributed 326 menstrual cycles). The study analyzed changes in observed cervical mucus discharge, various hormones in first morning urine, and serum progesterone. Transvaginal ultrasonography and cervical mucus helped identifying the day of ovulation. Changes in pregnanediol glucuronide levels during the luteal phase were examined and classified according to the length of that phase, a location parameter, and a scale parameter. Associations between nine pregnanediol glucuronide profiles and other hormone profiles were examined.
Results
Low periovulatory pregnanediol glucuronide levels and low periovulatory luteinizing hormone levels were associated with delayed increases in pregnanediol glucuronide after ovulation. That ‘delayed increase profile’ was more frequently associated with cycles with prolonged high LH levels than in cycles with rapid pregnanediol glucuronide increases. A ‘plateau-like profile’ during the luteal phase was associated with longer cycles, cycles with higher estrone-3-glucuronide and pregnanediol glucuronide during the preovulatory phase, and cycles with higher periovulatory pregnanediol glucuronide levels.
Conclusions
Distinct profiles of urinary progesterone levels are displayed during the luteal phase. These profiles relate to early hormone changes during the menstrual cycle. In everyday clinical practice, these findings provide further evidence for recommending progesterone test seven days after the mucus peak day. The search for other correlations and associations is underway.
Acknowledgments
The authors thank Drs. Sophie Dubus, Anne Leduy, Isabelle Ecochard, Marie Grisard Capelle, Enriqueta Barranco, Michele Barbato, Sandro Girotto, and Marion Gimmler from the natural family planning clinics as well as all the women who took part in this study.
-
Research funding: None declared.
-
Author contributions: Conceptualization, methodology, and investigation: SA, TB, RL, HB, and RE. Data curation and analysis: SA, HB, and RE. Result interpretation and validation: SA, TB, RL, HB, JI, and R. Writing, original draft: SA, TB, RL, and RE. Writing, review, and editing: TB, RL, HB, JI, and RE. All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
-
Competing interests: Authors state no conflict of interest.
-
Informed consent: Informed consent was obtained from all individuals included in this study.
-
Ethical approval: The local Institutional Review Board deemed the study exempt from review.
References
1. Alliende, ME. Mean versus individual hormonal profiles in the menstrual cycle. Fertil Steril 2002;78:90–6. https://doi.org/10.1016/s0015-0282(02)03167-9.Search in Google Scholar PubMed
2. Park, SJ, Goldsmith, LT, Skurnick, JH, Wojtczuk, A, Weiss, G. Characteristics of the urinary luteinizing hormone surge in young ovulatory women. Fertil Steril 2007;88:684–90. https://doi.org/10.1016/j.fertnstert.2007.01.045.Search in Google Scholar PubMed
3. Direito, A, Bailly, S, Mariani, A, Ecochard, R. Relationships between the luteinizing hormone surge and other characteristics of the menstrual cycle in normally ovulating women. Fertil Steril 2013;99:279–85. https://doi.org/10.1016/j.fertnstert.2012.08.047.Search in Google Scholar PubMed
4. Ecochard, R, Bouchard, B, Leiva, R, Abdulla, S, Dupuis, O, Duterque, O, et al.. Characterization of hormonal profiles during the luteal phase in regularly menstruating women. Fertil Steril 2017;108:175–82. https://doi.org/10.1016/j.fertnstert.2017.05.012.Search in Google Scholar PubMed
5. Ecochard, R, Guillerm, A, Leiva, R, Bouchard, T, Direito, A, Boehringer, H. Characterization of follicle stimulating hormone profiles in normal ovulating women. Fertil Steril 2014;102:237–43. https://doi.org/10.1016/j.fertnstert.2014.03.034.Search in Google Scholar PubMed
6. Abdullah, S, Bouchard, T, Klich, A, Leiva, R, Pyper, C, Genolini, C, et al.. A quadriparametric model to describe the diversity of waves applied to hormonal data. Methods Inf Med 2018;57:101–10. https://doi.org/10.3414/me17-01-0102.Search in Google Scholar
7. Abdulla, SH, Bouchard, TP, Leiva, RA, Boyle, P, Iwaz, J, Ecochard, R. Hormonal predictors of abnormal luteal phases in normally cycling women. Front Public Health 2018;6:144. https://doi.org/10.3389/fpubh.2018.00144.Search in Google Scholar PubMed PubMed Central
8. Ecochard, R, Duterque, O, Leiva, R, Bouchard, T, Vigil, P. Self-identification of the clinical fertile window and the ovulation period. Fertil Steril 2015;103:1319–25. https://doi.org/10.1016/j.fertnstert.2015.01.031.Search in Google Scholar PubMed
9. Ecochard, R, Gougeon, A. Side of ovulation and cycle characteristics in normally fertile women. Hum Reprod 2000;15:752–5. https://doi.org/10.1093/humrep/15.4.752.Search in Google Scholar PubMed
10. Ecochard, R, Marret, H, Rabilloud, M, Bradaï, R, Boehringer, H, Girotto, S, et al.. Sensitivity and specificity of ultrasound indices of ovulation in spontaneous cycles. Eur J Obstet Gynecol Reprod Biol 2000;91:59–64. https://doi.org/10.1016/s0301-2115(99)00249-3.Search in Google Scholar PubMed
11. Brown, JB, Blackwell, LF, Billings, JJ, Conway, B, Cox, RI, Garrett, G. Natural family planning. Am J Obstet Gynecol 1987;157:1082–9. https://doi.org/10.1016/s0002-9378(87)80137-0.Search in Google Scholar PubMed
12. Fehring, RJ. Review and analysis of the peak day. Curr Med Res 1999;10:11–9.Search in Google Scholar
13. Niswender, GD, Juengel, JL, Silva, PJ, Rollyson, MK, McIntush, EW. Mechanisms controlling the function and life span of the corpus luteum. Physiol Rev 2000;80:1–29. https://doi.org/10.1152/physrev.2000.80.1.1.Search in Google Scholar PubMed
14. Murphy, BD. Models of luteinisation. Biol Reprod 2000;63:2–11. https://doi.org/10.1095/biolreprod63.1.2.Search in Google Scholar PubMed
15. Devoto, L, Fuentes, A, Kohen, P, Cespedes, P, Palomino, A, Pommer, R. The human corpus luteum: life cycle and function in natural cycles. Fertil Steril 2009;92:1067–79. https://doi.org/10.1016/j.fertnstert.2008.07.1745.Search in Google Scholar PubMed
16. Jordan, J, Craig, K, Clifton, DK, Soules, MR. Luteal phase defect: the sensitivity and specificity of diagnostic methods in common clinical use. Fertil Steril 1994;62:54–62. https://doi.org/10.1016/s0015-0282(16)56815-0.Search in Google Scholar PubMed
17. Hilgers, T. The medical & surgical practice of NaProTechnology, 1st ed. Omaha: Pope Paul VI Institute Press; 2004.Search in Google Scholar
© 2022 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Letter to the Editor
- The role of gut microbiota in etiopathogenesis of long COVID syndrome
- Original Articles
- Risk factors and inflammatory markers in acute coronary syndrome-ST elevation myocardial infarction (STEMI)
- Association of pro-inflammatory cytokines, inflammatory proteins with atherosclerosis index in obese male subjects
- Exploration of meteorin-like peptide (metrnl) predictors in type 2 diabetic patients: the potential role of irisin, and other biochemical parameters
- Distinct urinary progesterone metabolite profiles during the luteal phase
- Promoter methylation levels of RASSF1 and ATIC genes are associated with lung cancer in Iranian patients
- Population status of selenium in Colombia and associated factors: a cross-sectional study
- Bambusa vulgaris leaves reverse mitochondria dysfunction in diabetic rats through modulation of mitochondria biogenic genes
- Increased expression of androgen receptor and PSA genes in LNCaP (prostate cancer) cell line due to high concentrations of EGCG, an active ingredient in green tea
- The effects of endurance exercise and metformin on memory impairment caused by diabetes
- Exercise modulation in inflammation and metabolic hormonal disorders of COVID-19 to decrease risk factors in coronary heart disease
- The effect of co-administration of artemisinin and N-acetyl cysteine on antioxidant status, spermatological parameters and histopathology of testis in adult male mice
- Case Report
- Unilateral ovarian agenesis with ipsilateral tubal presence – report of a case
- Review Articles
- Brown adipose tissue as an endocrine organ: updates on the emerging role of batokines
- Zuranolone and its role in treating major depressive disorder: a narrative review
Articles in the same Issue
- Frontmatter
- Letter to the Editor
- The role of gut microbiota in etiopathogenesis of long COVID syndrome
- Original Articles
- Risk factors and inflammatory markers in acute coronary syndrome-ST elevation myocardial infarction (STEMI)
- Association of pro-inflammatory cytokines, inflammatory proteins with atherosclerosis index in obese male subjects
- Exploration of meteorin-like peptide (metrnl) predictors in type 2 diabetic patients: the potential role of irisin, and other biochemical parameters
- Distinct urinary progesterone metabolite profiles during the luteal phase
- Promoter methylation levels of RASSF1 and ATIC genes are associated with lung cancer in Iranian patients
- Population status of selenium in Colombia and associated factors: a cross-sectional study
- Bambusa vulgaris leaves reverse mitochondria dysfunction in diabetic rats through modulation of mitochondria biogenic genes
- Increased expression of androgen receptor and PSA genes in LNCaP (prostate cancer) cell line due to high concentrations of EGCG, an active ingredient in green tea
- The effects of endurance exercise and metformin on memory impairment caused by diabetes
- Exercise modulation in inflammation and metabolic hormonal disorders of COVID-19 to decrease risk factors in coronary heart disease
- The effect of co-administration of artemisinin and N-acetyl cysteine on antioxidant status, spermatological parameters and histopathology of testis in adult male mice
- Case Report
- Unilateral ovarian agenesis with ipsilateral tubal presence – report of a case
- Review Articles
- Brown adipose tissue as an endocrine organ: updates on the emerging role of batokines
- Zuranolone and its role in treating major depressive disorder: a narrative review